EYLEA
EYLEA
Approved
DIN Number
02505355
Drug Class
Human
Market Date
Nov 17, 2020
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505355
AIG Number0154950001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
S01LA05 AFLIBERCEPT
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AFLIBERCEPTActive
Strength: 2 MG / 0.05 ML
Monograph: AFLIBERCEPT